Regulus Therapeutics
Insider trading & Transactions

Last updated: 7 Aug 2014

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	7 Aug 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,600	N/A	N/A
Sale	6 Aug 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,150	N/A	N/A
Sale	6 Aug 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,150	N/A	N/A
Sale	5 Aug 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	3,505	N/A	N/A
Option	5 Aug 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	3,505	N/A	N/A
Option	5 Aug 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	3,505	N/A	N/A
Sale	1 Aug 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	2,600	N/A	N/A
Sale	1 Aug 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,600	N/A	N/A
Sale	31 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,750	N/A	N/A
Sale	31 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,750	N/A	N/A
Sale	30 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,000	N/A	N/A
Sale	30 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,000	N/A	N/A
Sale	25 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	25 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	24 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,850	N/A	N/A
Sale	24 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,850	N/A	N/A
Sale	23 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	23 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	18 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	5,000	N/A	N/A
Sale	18 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	5,000	N/A	N/A
Sale	17 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	5,000	N/A	N/A
Sale	17 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	5,000	N/A	N/A
Sale	16 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,500	N/A	N/A
Sale	16 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,500	N/A	N/A
Sale	11 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,750	N/A	N/A
Sale	11 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,750	N/A	N/A
Sale	10 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	4,500	N/A	N/A
Sale	10 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	4,500	N/A	N/A
Sale	9 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,800	N/A	N/A
Sale	9 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,800	N/A	N/A
Sale	3 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,200	N/A	N/A
Sale	3 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,200	N/A	N/A
Sale	2 Jul 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,100	N/A	N/A
Sale	2 Jul 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,100	N/A	N/A
Sale	1 Jul 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	3,505	N/A	N/A
Option	1 Jul 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Stock Option (Right to Buy)	2,500	N/A	N/A
Option	1 Jul 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	3,505	N/A	N/A
Sale	1 Jul 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	2,500	N/A	N/A
Option	1 Jul 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	2,500	N/A	N/A
Option	1 Jul 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	3,505	N/A	N/A
Sale	27 Jun 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,150	N/A	N/A
Sale	27 Jun 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,150	N/A	N/A
Sale	26 Jun 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	26 Jun 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	1,700	N/A	N/A
Sale	25 Jun 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,750	N/A	N/A
Sale	25 Jun 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	2,750	N/A	N/A
Sale	17 Jun 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	5,000	N/A	N/A
Option	17 Jun 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	5,000	N/A	N/A
Option	17 Jun 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Stock Option (Right to Buy)	5,000	N/A	N/A
Option	9 Jun 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	3,505	N/A	N/A

Showing 300 to 350 of 397 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Regulus Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Regulus Therapeutics
Insider trading & Transactions